Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains.
Ting PanZhongwei HuFengyu HuYiwen ZhangBingfeng LiuChangwen KeQiumin SheXin HeXiaoping TangHui ZhangPublished in: Cellular & molecular immunology (2021)